Noteworthily, compared to primary tumors, recurrent gliomas more frequently exhibit features such as copy number variations (CNV), combined IDH1 and TERT mutations, compromised cell cycle signaling pathways, and low tumor mutational burden (TMB) [31]. Here, IDH1 is linked to central nervous system cancer.